The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
CCL
Vol.
35
No.
2
February 24, 2012
- ASCO Recommends Beginning Palliative Care Alongside Standard Therapy in Metastatic NSCLC
- New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up
- AGS-003 Increased Survival In Combination with Sunitinib
- In Phase II Study, Vaccine IMA910 Stimulated Immune Response
- Researchers Identify Subtype Demonstrating Angiogenesis
- MicroRNA Biomarkers Linked To Early-Stage Prostate Cancer
- Imaging Technique Identifies Consequences Of Mutation
- Researchers Call For New Approach To Peripheral Neuropathy Testing
- Digital Microscope Blood Test Identifies Circulating Tumor Cells
- Study Links Breast, Pancreatic Cancer Risks to Lynch Syndrome
- Sarcoma, Li-Fraumeni Linked; Genetic Counseling Recommended
- Pathology In Operating Suite Cuts Need for More Surgery
- UHC Expands Risk Models To Include 25 Cancer Variables
- Trials Approved by NCI CTEP For The Month of February
- Agency Expands Gleevec Label To Include Rare GIST Subset
TCL
Vol.
38
No.
09
March 02, 2012
- Importation Is Remedy of Last Resort in Effort to Obtain Generic Injectables
- News Analysis: The Political Economy of Importation to Alleviate Cancer Drug Shortages
- HHS Agency Says It Has No Jurisdiction And No Cause to Act on I-ELCAP Allegations
- Michael Atkins Named Deputy Director at Georgetown Lombardi Cancer Center
CCL
Vol.
35
No.
3
March 30, 2012
- Committee Unblinds Phase III Zytiga Study
- USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears
- Tobacco Control and Prevention Saved 795,000 Lives Between 1975-2000, Study Shows
- Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005
- Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit
- Study: Freezing Secondary Tumors Helpful in Metastatic Breast Cancer
- Women Who Received CMF Chemotherapy Score Lower On Cognitive Skill Exams
- Three Studies Demonstrate Oncotype DX Test Effectiveness
- ACG Highlights Link Between Obesity and Colorectal Cancer
- Olaparib Study Demonstrates No Changes In Overall Survival
- Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study
- Trials Approved by NCI CTEP For the Month of March